IsoPlexis, the leader in single-cell functional proteomics, announced today that Chief Executive Officer and Co-Founder, Sean Mackay , will present at Evercore ISI’s 3 rd Annual HealthCONx Conference on Wednesday, December 2 nd at 9:40 a.m. ET .
| BRANFORD, Conn., Nov. 25, 2020 /PRNewswire/ -- Isoplexis, the leader in single-cell functional proteomics, announced today that Chief Executive Officer and Co-Founder, Sean Mackay, will present at Evercore ISI’s 3rd Annual HealthCONx Conference on Wednesday, December 2nd at 9:40 a.m. ET.
A live webcast of the fireside chat will be made available on the company’s website at isoplexis.com. ABOUT ISOPLEXIS: IsoPlexis (www.isoplexis.com) is dedicated to accelerating the fight against cancer and a range of the world’s toughest diseases with its uniquely correlative, award-winning, single-cell proteomics systems. By revealing unique immune biomarkers in small subsets of cells, we are advancing immunotherapies and targeted therapies to a more highly precise and personalized stage. Our award winning integrated systems are used globally to advance the field of immune biology and biomarkers as we generate solutions to overcome the challenges of complex diseases. MEDIA CONTACT:
SOURCE IsoPlexis |
View original content to download multimedia:
